After 6 months, placebo was associated with a mean weight gain of 0.4 kg (o.88 lb), compared with 1.2-1.9 kg (2.6-4.2 lb) ...

US President Donald Trump has signed an executive order that aims to reduce high prescription drug prices – but its details ...

Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...

Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

There are significant questions on how the order can be implemented, and if companies can raise prices on already approved ...

The president has long complained that the United States pays more for medicines than other wealthy countries. But he offered ...

We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look ...

Dr. Binks joins Capricor in anticipation of potential approval of deramiocel in Q3 2025, bringing extensive experience in ...

The order calls on the health department, led by Robert F. Kennedy Jr., to broker new price tags for drugs over the next ...

A four-year saga will reach its climax on Wednesday, but the Commission president is likely to emerge relatively unscathed.

Older patients with Crohn’s disease are at elevated risk for recurrence following ileocolic resection but less frequently ...